Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jun 15;6(7):1441-4.
Print 2013.

Pleomorphic lobular carcinoma in a male breast: a case report with review of the literature

Affiliations
Review

Pleomorphic lobular carcinoma in a male breast: a case report with review of the literature

Mitsuaki Ishida et al. Int J Clin Exp Pathol. .

Abstract

Invasive lobular carcinoma (ILC) is a distinct type of breast carcinoma and represents 5-15% of invasive breast carcinomas in female. However, the occurrence of ILC is exceptional in male breast, and the incidence is 1.5-1.9% of male breast carcinomas. Herein, we report a case of pleomorphic lobular carcinoma in a male breast. A 76-year-old Japanese male with a history of treatment with a progestational agent for prostate cancer presented with a right breast tumor. Magnetic resonance imaging showed gynecomastia of bilateral breasts and an irregular-shaped nodule in his right breast. Histopathological study revealed infiltrative neoplastic growth of discohesive tumor cells arranged in single-filed linear cords or trabeculae. These neoplastic cells had variable-sized large nuclei containing occasional nucleoli. Immunohistochemically, these tumor cells lacked E-cadherin expression. Accordingly, an ultimate diagnosis of pleomorphic lobular carcinoma was made. This is the third documented case of pleomorphic lobular carcinoma of male breast. Our analyses of the clinicopathological features of this type of tumor revealed that patients were middle-aged or elderly men, and all cases were free from lymph node metastases or recurrence. Gynecomastia and a history of hormonal agent intake were present only in the current case. The most commonly proposed risk factor for the development of male breast cancer is elevated level of estrogen, and a possible link between the development of male breast cancer and estrogen therapy for prostate cancer has been suggested. The clinicopathological features of ILC of male breast remains unclear; therefore, additional studies are needed to clarify them.

Keywords: Lobular carcinoma; male breast; pleomorphic variant.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Magnetic resonance imaging shows an irregular-shaped nodule in the right breast and gynecomastia of the bilateral breasts.
Figure 2
Figure 2
Histopathological findings of the resected breast. A. Linear cord of atypical epithelial cells. The neoplastic cells have variable-sized large round nuclei with occasional nucleoli. HE, x 400. B. Gynecomastia is observed in the surrounding breast tissue. HE, x 100.
Figure 3
Figure 3
Immunohistochemical findings of the breast nodule. E-cadherin is not expressed in the neoplastic cells (Note: non-neoplastic ductal cells are positive for E-cadherin). x 200.

References

    1. Reiner A, Badve S. Carcinoma of the male breast. In: Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ, editors. World Health Organization Classification of Tumours of the Breast. Lyon: IARC Press; 2012. pp. 168–169.
    1. Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer. 2004;101:51–57. - PubMed
    1. Goss PE, Reid C, Pintilie M, Lim R, Miller B. Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer. 1999;85:629–639. - PubMed
    1. Erhan Y, Zekioglu O, Erhan Y. Invasive lobular carcinoma of the male breast. Can J Surg. 2006;49:365–366. - PMC - PubMed
    1. Briest S, Vang R, Terrell K, Emens L, Lange JR. Invasive lobular carcinoma of the male breast: a rare histology in an uncommon disease. Breast Care. 2009;4:36–38. - PMC - PubMed

MeSH terms